M Protein and Hyaluronic Acid Capsule Are Essential for In Vivo Selection of covRS Mutations Characteristic of Invasive Serotype M1T1 Group A Streptococcus
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The initiation of hyperinvasive disease in group A Streptococcus (GAS) serotype M1T1 occurs by mutation within the covRS two-component regulon (named covRS for c ontrol o f v irulence r egulatory s ensor kinase), which promotes resistance to neutrophil-mediated killing through the upregulation of bacteriophage-encoded Sda1 DNase. To determine whether other virulence factors contribute to this phase-switching phenomenon, we studied a panel of 10 isogenic GAS serotype M1T1 virulence gene knockout mutants. While loss of several individual virulence factors did not prevent GAS covRS switching in vivo , we found that M1 protein and hyaluronic acid capsule are indispensable for the switching phenotype, a phenomenon previously attributed uniquely to the Sda1 DNase. We demonstrate that like M1 protein and Sda1, capsule expression enhances survival of GAS serotype M1T1 within neutrophil extracellular traps. Furthermore, capsule shares with M1 protein a role in GAS resistance to human cathelicidin antimicrobial peptide LL-37. We conclude that a quorum of GAS serotype M1T1 virulence genes with cooperative roles in resistance to neutrophil extracellular killing is essential for the switch to a hyperinvasive phenotype in vivo . IMPORTANCE The pathogen group A Streptococcus (GAS) causes a wide range of human infections ranging from the superficial “strep throat” to potentially life-threatening conditions, such as necrotizing fasciitis, also known as “flesh-eating disease.” A marked increase in the number of cases of severe invasive GAS infection during the last 30 years has been traced to the emergence and spread of a single clone of the M1T1 serotype. Recent studies have shown that GAS serotype M1T1 bacteria undergo a genetic “switch” in vivo to a hypervirulent state that allows dissemination into the bloodstream. The present study was undertaken to identify specific GAS serotype M1T1 virulence factors required for this switch to hypervirulence. The surface-anchored GAS M1 protein and hyaluronic acid capsule are found to be essential for the switching phenotype, and a novel role for capsule in GAS resistance to host defense peptides and neutrophil extracellular killing is revealed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beneficial suicide: why neutrophils die to make NETs
Brinkmann, V., & Zychlinsky, A. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1710 · Cited by 937 · cited 1×
“Cathelicidin antimicrobial peptides are important effectors of bacterial killing within NETs (20, 21), and inhibition of human cathelicidin LL-37 is a key factor by which M1 protein promotes NET resistance (12).”
BackgroundHyaluronic acid capsule is a virulence factor for mucoid group A streptococci.
Wessels, M. R., Moses, A. E., Goldberg, J. B., & DiCesare, T. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8317 · Cited by 351 · cited 1×
“Acapsular GAS mutants are sensitive to phagocytic killing in vitro and have reduced virulence in a murine model of invasive infection compared with the encapsulated WT strain (35, 36).”
BackgroundThe IL-8 Protease SpyCEP/ScpC of Group A Streptococcus Promotes Resistance to Neutrophil Killing
Zinkernagel, A. S., Timmer, A. M., Pence, M. A., Locke, J. B., Buchanan, J. T., Turner, C. E., Mishalian, I., Sriskandan, S., Hanski, E., & Nizet, V. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.07.002 · Cited by 184 · cited 3×
“The isogenic in-frame allelic exchange knockout mutants 5448 cepA (16), 5448 dltA (17), 5448 nga (13), 5448 emm1 (12), 5448 slo (13), 5448 lsa (18), 5448 speB (10), 5448 sagA (14), and 5448 pili (15) have been described previously.”
BackgroundSelf-citation
Cited by
Neutrophil Extracellular Traps: Double-Edged Swords of Innate Immunity
Kaplan, M. J., & Radic, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201719 · Cited by 1,171
Programmed cell death as a defence against infection
Jorgensen, I., Rayamajhi, M., & Miao, E. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.147 · Cited by 1,026
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908
“The expression of the M protein and hyaluronic acid cap- April 2014 Volume 27 Number 2 cmr.asm.org 273 sule enhances GAS survival within NETs by increasing bacterial resistance to the antimicrobial peptide LL-37 (201).”
BackgroundInfluentialSelf-citationAntibiotic Modulation of Capsular Exopolysaccharide and Virulence in Acinetobacter baumannii
Geisinger, E., & Isberg, R. R. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004691 · Cited by 548
Molecular insight into invasive group A streptococcal disease
Cole, J. N., Barnett, T. C., Nizet, V., & Walker, M. J. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2648 · Cited by 377
Self-citation
Metadata
- Authors
- Cole, J. N., Pence, M. A., von Köckritz-Blickwede, M., Hollands, A., Gallo, R. L., Walker, M. J., & Nizet, V.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2010-10-29
- Volume
- 1
- Issue
- 4
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2161619131
- Cited by
- 136
- References
- 3
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.